Home Healthcare Healthcare Services Maternal Mental Health Market

Maternal Mental Health Market Size, Share & Trends Analysis Report By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others), By Treatment (Antidepressants, Interpersonal Psychotherapy (IPT), Cognitive Behavioral Therapy (CBT), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR6669DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Maternal Mental Health Market Size Analysis
    1. Introduction
    2. Maternal Mental Health Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Postpartum Depression
      2. Dysthymia
      3. Pregnancy and Postpartum General Anxiety
      4. Pregnancy and Postpartum OCD
      5. Birth-Related PTSD
      6. Others
    3. Maternal Mental Health Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Antidepressants
        1. Selective serotonin reuptake inhibitors (SSRIs)
        2. Tricyclic antidepressants (TCAs)
        3. Others
      2. Interpersonal Psychotherapy (IPT)
      3. Cognitive Behavioral Therapy (CBT)
      4. Others
  7. North America Maternal Mental Health Market Size Analysis
    1. Introduction
    2. Maternal Mental Health Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Postpartum Depression
      2. Dysthymia
      3. Pregnancy and Postpartum General Anxiety
      4. Pregnancy and Postpartum OCD
      5. Birth-Related PTSD
      6. Others
    3. Maternal Mental Health Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Antidepressants
        1. Selective serotonin reuptake inhibitors (SSRIs)
        2. Tricyclic antidepressants (TCAs)
        3. Others
      2. Interpersonal Psychotherapy (IPT)
      3. Cognitive Behavioral Therapy (CBT)
      4. Others
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
  8. Europe Maternal Mental Health Market Size Analysis
    1. Introduction
    2. Maternal Mental Health Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Postpartum Depression
      2. Dysthymia
      3. Pregnancy and Postpartum General Anxiety
      4. Pregnancy and Postpartum OCD
      5. Birth-Related PTSD
      6. Others
    3. Maternal Mental Health Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Antidepressants
        1. Selective serotonin reuptake inhibitors (SSRIs)
        2. Tricyclic antidepressants (TCAs)
        3. Others
      2. Interpersonal Psychotherapy (IPT)
      3. Cognitive Behavioral Therapy (CBT)
      4. Others
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    6. France
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
  9. APAC Maternal Mental Health Market Size Analysis
    1. Introduction
    2. Maternal Mental Health Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Postpartum Depression
      2. Dysthymia
      3. Pregnancy and Postpartum General Anxiety
      4. Pregnancy and Postpartum OCD
      5. Birth-Related PTSD
      6. Others
    3. Maternal Mental Health Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Antidepressants
        1. Selective serotonin reuptake inhibitors (SSRIs)
        2. Tricyclic antidepressants (TCAs)
        3. Others
      2. Interpersonal Psychotherapy (IPT)
      3. Cognitive Behavioral Therapy (CBT)
      4. Others
    4. China
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    7. India
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
  10. Middle East and Africa Maternal Mental Health Market Size Analysis
    1. Introduction
    2. Maternal Mental Health Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Postpartum Depression
      2. Dysthymia
      3. Pregnancy and Postpartum General Anxiety
      4. Pregnancy and Postpartum OCD
      5. Birth-Related PTSD
      6. Others
    3. Maternal Mental Health Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Antidepressants
        1. Selective serotonin reuptake inhibitors (SSRIs)
        2. Tricyclic antidepressants (TCAs)
        3. Others
      2. Interpersonal Psychotherapy (IPT)
      3. Cognitive Behavioral Therapy (CBT)
      4. Others
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
  11. LATAM Maternal Mental Health Market Size Analysis
    1. Introduction
    2. Maternal Mental Health Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Postpartum Depression
      2. Dysthymia
      3. Pregnancy and Postpartum General Anxiety
      4. Pregnancy and Postpartum OCD
      5. Birth-Related PTSD
      6. Others
    3. Maternal Mental Health Market Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
      1. Antidepressants
        1. Selective serotonin reuptake inhibitors (SSRIs)
        2. Tricyclic antidepressants (TCAs)
        3. Others
      2. Interpersonal Psychotherapy (IPT)
      3. Cognitive Behavioral Therapy (CBT)
      4. Others
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      3. Market Size & Forecast By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
  12. Competitive Landscape
    1. Maternal Mental Health Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Canopie
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Brightside Health Inc.
    3. March of Dimes
    4. Mammha
    5. Viatris Inc.
    6. GSK plc.
    7. Alembic Pharmaceuticals Limited
    8. Mallinckrodt
    9. Sage Therapeutics, Inc.
    10. Bausch Health Companies Inc.
    11. Magellan Health, Inc.
    12. Pfizer Inc.
    13. Therapy Mama
    14. AstraZeneca
    15. Eli Lilly and Company
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.